Ignite Creation Date:
2024-05-06 @ 3:58 PM
Last Modification Date:
2024-10-26 @ 2:01 PM
Study NCT ID:
NCT04827745
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-03-18
First Post:
2021-03-25
Brief Title:
Blinatumomab for Treatment of RR or MRD-positive CD19-Positive MPAL
Sponsor:
Organization:
University of Maryland Baltimore